Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II

被引:0
|
作者
Falkai, Peter [1 ]
Dombi, Zsofia Borbala [2 ,3 ]
机构
[1] Ludwig Maximilian Univ Munich, Univ Hosp, Dept Psychiat & Psychotherapy, Munich, Germany
[2] Gedeon Richter Plc, Global Med Div, Budapest, Hungary
[3] Univ Oxford, Dept Psychiat, Oxford, England
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
关键词
partial agonists; dopamine; symptom-based treatment; real-world evidence; antipsychotic; NEGATIVE SYMPTOMS; SCHIZOPHRENIA;
D O I
10.3389/fpsyt.2023.1266566
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页数:3
相关论文
共 2 条
  • [1] Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists
    Nemeth, Gyorgy
    Csehi, Reka
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [2] The position statement of the Working Group of the Polish Psychiatric Association on the use of D2/D3 dopamine receptor partial agonists in the treatment of mental disorders
    Wichniak, Adam
    Samochowiec, Jerzy
    Szulc, Agata
    Dudek, Dominika
    Heitzman, Janusz
    Janas-Kozik, Malgorzata
    Wolanczyk, Tomasz
    Rymaszewska, Joanna
    Siwek, Marcin
    Bienkowski, Przemyslaw
    PSYCHIATRIA POLSKA, 2021, 55 (05) : 941 - 966